Neuro-Oncology Reviews
Volume
24 Number 20
31 October 2022
Home > Publications > Neuro-Oncology Reviews > Volume 24, Year 2022 > Number 20, 31 October
Knisely
JPS, Fine HA.
Reirradiation
for Recurrent Glioblastoma: What We Know and What We Do Not.
J
Clin Oncol. 2022 Oct 19:JCO2201785→.
doi: 10.1200/JCO.22.01785→.
PMID: 36260825→.
Case report, Review. ˍ
Mackenzie
P, Vajdic C, Delaney G, Comans T, Morris L, Agar M, Gabriel G,
Barton M.
Radiotherapy
utilisation rates for patients with cancer as a function of age: A
systematic review.
J
Geriatr Oncol. 2022 Oct 19:S1879-4068(22)00236-3→.
doi: 10.1016/j.jgo.2022.10.002→.
PMID: 36272958→.
Review˰ ˍ
Marabitti
V, Giansanti M, De Mitri F, Gatto F, Mastronuzzi A, Nazio
F.
Pathological
implications of metabolic reprogramming and its therapeutic
potential in medulloblastoma.
Front
Cell Dev Biol. 2022 Oct 19;10:1007641→.
doi: 10.3389/fcell.2022.1007641→.
PMID: 36340043→.
Review. ˍ
Andersen
BM, Reardon DA.
Immunotherapy
approaches for adult glioma: knowledge gained from recent clinical
trials.
Curr
Opin Neurol. 2022 Oct 21;35(6):803-813→.
doi: 10.1097/WCO.0000000000001118→.
PMID: 36367046→.
Review˰ ˍ
*
Jovanovich
N, Habib A, Head J, Anthony A, Edwards L, Zinn PO.
Opinion:
Bridging gaps and doubts in glioblastoma cell-of-origin.
Front
Oncol. 2022 Oct 21;12:1002933→.
doi: 10.3389/fonc.2022.1002933→.
PMID: 36338762→.
Opinion. ˍ
Mallick
S, Benson R, Venkatesulu B, Melgandi W, Rath GK.
Systematic
Review and Individual Patient Data Analysis of Uncommon Variants
of Glioblastoma: An Analysis of 196 Cases.
Neurol
India. 2022 Oct 21;70(5):2086-2092→.
doi: 10.4103/0028-3886.359222→.
PMID: 36352613→.
Review. ˍ
Niemi
JVL, Sokolov AV, Schiöth HB.
Neoantigen
Vaccines; Clinical Trials, Classes, Indications, Adjuvants and
Combinatorial Treatments.
Cancers
(Basel). 2022 Oct 21;14(20):5163→.
doi: 10.3390/cancers14205163→.
PMID: 36291947→.
Review. ˍ
Sachdeva
P, Ghosh S, Ghosh S, Han S, Banerjee J, Bhaskar R, Sinha
JK.
Childhood
Obesity: A Potential Key Factor in the Development of Glioblastoma
Multiforme.
Life
(Basel). 2022 Oct 21;12(10):1673→.
doi: 10.3390/life12101673→.
PMID: 36295107→.
Review. ˍ
Yuile
A, Satgunaseelan L, Wei J, Kastelan M, Back MF, Lee M, Wei H,
Buckland ME, Lee A, Wheeler HR.
Implications
of Concurrent IDH1
and
IDH2
Mutations
on Survival in Glioma-A Case Report and Systematic Review.
Curr
Issues Mol Biol. 2022 Oct 21;44(10):5117-5125→.
doi: 10.3390/cimb44100348→.
PMID: 36286062→.
Case report, Review. ˍ
Malhotra
AK, Karthikeyan V, Zabih V, Landry A, Bennett J, Bartels U, Nathan
PC, Tabori U, Hawkins C, Das S, Gupta S.
Adolescent
and young adult glioma: systematic review of demographic, disease,
and treatment influences on survival.
Neurooncol
Adv. 2022 Oct 22;4(1):vdac168→.
doi: 10.1093/noajnl/vdac168→.
PMID: 36479061→.
Review. ˍ
Fioni
F, Song JC, Ma ZL, Ghalwash AA.
Differentiation
of high grade glioma and solitary brain metastases by measuring
relative cerebral blood volume and fractional anisotropy: A
systematic review and Meta-Analysis of MRI diagnostic test
accuracy studies.
Br
J Radiol. 2022 Oct 24:20220052→.
doi: 10.1259/bjr.20220052→.
PMID: 36278795→.
Review, Meta-analysis. ˍ
Lehrer
EJ, Kowalchuk RO, Ruiz-Garcia H, Merrell KW, Brown PD, Palmer JD,
Burri SH, Sheehan JP, Quninoes-Hinojosa A, Trifiletti
DM.
Preoperative
stereotactic radiosurgery in the management of brain metastases
and gliomas.
Front
Surg. 2022 Oct 24;9:972727→.
doi: 10.3389/fsurg.2022.972727→.
PMID: 36353610→.
Review. ˍ
Ling
SP, Ming LC, Dhaliwal JS, Gupta M, Ardianto C, Goh KW, Hussain Z,
Shafqat N.
Role
of Immunotherapy in the Treatment of Cancer: A Systematic
Review.
Cancers
(Basel). 2022 Oct 24;14(21):5205→.
doi: 10.3390/cancers14215205→.
PMID: 36358624→.
Review. ˍ
Li
H, Duan Y, Liu N, Dong J, Liang Y, Ju R.
Value
of DWI Combined with Magnetic Resonance Spectroscopy in the
Differential Diagnosis between Recurrent Glioma and Radiation
Injury: A Meta-Analysis.
Int
J Clin Pract. 2022 Oct 25;2022:1629570→.
doi: 10.1155/2022/1629570→.
PMID: 36380750→.
Meta-analysis. ˍ
Bunse
L, Bunse T, Krämer C, Chih YC, Platten M.
Clinical
and Translational Advances in Glioma
Immunotherapy.
Neurotherapeutics.
2022 Oct 27→.
doi: 10.1007/s13311-022-01313-9→.
PMID: 36303101→.
Review. ˍ
Giambra
M, Di Cristofori A, Valtorta S, Manfrellotti R, Bigiogera V, Basso
G, Moresco RM, Giussani C, Bentivegna A.
The
peritumoral brain zone in glioblastoma: where we are and where we
are going.
J
Neurosci Res. 2022 Oct 27→.
doi: 10.1002/jnr.25134→.
PMID: 36300592→.
Review. ˍ
Lim
YJ.
Medical
Treatment of Pediatric Low-Grade Glioma.
Brain
Tumor Res Treat. 2022 Oct 27;10(4):221-225→.
doi: 10.14791/btrt.2022.0039→.
PMID: 36347636→.
Review. ˍ
Schirrmacher
V, van Gool S, Stuecker W.
Counteracting
Immunosuppression in the Tumor Microenvironment by Oncolytic
Newcastle Disease Virus and Cellular Immunotherapy.
Int
J Mol Sci. 2022 Oct 27;23(21):13050→.
doi: 10.3390/ijms232113050→.
PMID: 36361831→.
Review. ˍ
Hosseinalizadeh
H, Habibi Roudkenar M, Mohammadi Roushandeh A, Kuwahara Y, Tomita
K, Sato T.
Natural
killer cell immunotherapy in glioblastoma.
Discov
Oncol. 2022 Oct 28;13(1):113→.
doi: 10.1007/s12672-022-00567-1→.
PMID: 36305981→.
Review. ˍ
Kutty
S.
A
summary of common grading systems used in neurosurgical
practice.
Surg
Neurol Int. 2022 Oct 28;13:497→.
doi: 10.25259/SNI_731_2022→.
PMID: 36447867→.
Review. ˍ
Li
J, Feng L, Lu Y.
Glioblastoma
multiforme: Diagnosis, treatment, and invasion.
J
Biomed Res. 2022 Oct 28:1-11→.
doi: 10.7555/JBR.36.20220156→.
PMID: 36403983→.
Review. ˍ
Luo
Y, Tian G, Fang X, Bai S, Yuan G, Pan Y.
Ferroptosis
and Its Potential Role in Glioma: From Molecular Mechanisms to
Therapeutic Opportunities.
Antioxidants
(Basel). 2022 Oct 28;11(11):2123→.
doi: 10.3390/antiox11112123→.
PMID: 36358495→.
Review. ˍ
Qi
X, Jha SK, Jha NK, Dewanjee S, Dey A, Deka R, Pritam P, Ramgopal
K, Liu W, Hou K.
Antioxidants
in brain tumors: current therapeutic significance and future
prospects.
Mol
Cancer. 2022 Oct 28;21(1):204→.
doi: 10.1186/s12943-022-01668-9→.
PMID: 36307808→.
Review. ˍ
Fabbro
S, Pegolo E, Piccolo D, Cramaro A, Mascarin M, Coassin E, Skrap M,
Tuniz F.
Primary
Leptomeningeal Medulloblastoma in Adults: A Diagnostic
Challenge-Case Report and Systematic Review.
Asian
J Neurosurg. 2022 Oct 29;17(4):651-655→.
doi: 10.1055/s-0042-1757726→.
PMID: 36570761→.
Case report, Review. ˍ
Catalano
M, Serpe C, Limatola C.
Microglial
Extracellular Vesicles as Modulators of Brain Microenvironment in
Glioma.
Int
J Mol Sci. 2022 Oct 29;23(21):13165→.
doi: 10.3390/ijms232113165→.
PMID: 36361947→.
Review. ˍ
Foo
CY, Munir N, Kumaria A, Akhtar Q, Bullock CJ, Narayanan A, Fu
RZ.
Medical
Device Advances in the Treatment of Glioblastoma.
Cancers
(Basel). 2022 Oct 29;14(21):5341→.
doi: 10.3390/cancers14215341→.
PMID: 36358762→.
Review. ˍ
Goldman
M, Lucke-Wold B, Martinez-Sosa M, Katz J, Mehkri Y, Valisno J,
Quintin S.
Steroid
utility, immunotherapy, and brain tumor management: an update on
conflicting therapies.
Explor
Target Antitumor Ther. 2022 Oct 31;3(5):659-675→.
doi: 10.37349/etat.2022.00106→.
PMID: 36338521→.
Review. ˍ
Szklener
K, Mazurek M, Wieteska M, Wacławska M, Bilski M, Mańdziuk
S.
New
Directions in the Therapy of Glioblastoma.
Cancers
(Basel). 2022 Oct 31;14(21):5377→.
doi: 10.3390/cancers14215377→.
PMID: 36358795→.
Review. ˍ